Who
Shehnaaz Suliman
Director
Company insider
Files Form 4 as: Director, 10x Genomics; Director, Ultragenyx Pharmaceutical; President and COO, Alector; SVP, Corp Dev & Strategy, Theravance Biopharma.
In numbers
- Trades disclosed
- 79
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $8.5M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 1 Aug 2017
- Last trade
- 22 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $23K292 at $78.20 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $49K614 at $79.51 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $107K1,325 at $80.82 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $185K2,270 at $81.67 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $101K1,222 at $82.28 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $23K292 at $78.20 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $49K614 at $79.51 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $107K1,325 at $80.82 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $185K2,270 at $81.67 | filing |
| 22 Sep 2026filed 24 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $101K1,222 at $82.28 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $35K561 at $62.73 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $105K1,646 at $63.97 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $35K561 at $62.73 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $105K1,646 at $63.97 | filing |
| 16 Jun 2026filed 18 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $175K5,359 at $32.59 | filing |
| 16 Jun 2026filed 18 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $12K364 at $33.27 | filing |
| 16 Jun 2026filed 18 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $175K5,359 at $32.59 | filing |
| 16 Jun 2026filed 18 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $12K364 at $33.27 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
News
7,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Buys Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)RARE · themarketsdaily.com · 15 Oct 2026Ultragenyx (NASDAQ: RARE) agrees to sell PRV for $203 million in cashRARE · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Shehnaaz Suliman; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.